TCBPTC BioPharm (Holdings) plc

Nasdaq tcbiopharm.com


$ 5.29 $ 1.24 (30.24 %)    

Thursday, 29-Aug-2024 15:57:43 EDT
QQQ $ 471.89 $ -0.69 (-0.15 %)
DIA $ 413.95 $ 2.57 (0.62 %)
SPY $ 559.30 $ 0.05 (0.01 %)
TLT $ 97.51 $ -0.32 (-0.33 %)
GLD $ 232.94 $ 1.20 (0.52 %)
$ 5.34
$ 5.12 x 1,060
-- x --
-- - --
$ 2.11 - $ 1,280.00
817,112
na
52.81M
$ -16,376.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tc-biopharm-closes-public-offering-of-2m-adss-and-series-g-warrants-at-1-per-ads

Warrants Priced At £0.78 Per ADS, Expiring In One Year

 why-tc-biopharm-tcbp-stock-is-down-40

TC BioPharm shares are trading lower by 44% Wednesday morning. The company announced the pricing of an offering of 2 million un...

 tc-biopharm-has-been-granted-european-patent-number-ep3283620-titled-modified-gamma-delta-cells-and-uses-thereof-for-the-treatment-of-cancer-or-infectious-diseases

https://register.epo.org/application?number=EP16721208 

 tcbp-launches-compassionate-use-program-for-tcb008

The Company's lead therapeutic will be available through a newly opened compassionate use programEDINBURGH, Scotland, May 1...

 tc-biopharm-announces-exercise-of-warrants-for-31-million-gross-proceeds

TC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ:TCBP), a clinical stage biotechnology compa...

Core News & Articles
Market-Moving News for May 6th
05/06/2024 12:44:41

EYPT: -42% | EyePoint Pharmaceuticals shares are trading lower after the company's Phase 2 PAVIA trial of DURAVYU did not m...

 tc-biopharm-announces-execution-of-second-non-binding-loi-for-acquisition-targeting-innovative-car-t-therapies-financial-terms-not-disclosed

Acquisition target has established proof of concept data demonstrating the therapeutic potential for the treatment of multiple ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION